Forbes August 5, 2024
Achint Kumar is the CEO of Hypatia-AI.
The healthcare industry is on the cusp of a major transformation driven by the convergence of advanced technology and regulatory shifts. The FDA approval for the over-the-counter sale of continuous glucose monitoring (CGM) devices without a prescription has set the stage for a new era in personal health monitoring.
This development opens the door for innovations that aim to enhance the accuracy, accessibility and comprehensiveness of health data available to consumers. This article explores the current market landscape and the transformative potential of the healthcare industry’s integrated approach to monitoring.
Understanding The Current CGM Landscape
Let’s start by looking at the current market leaders. Dexcom is a pioneer in the CGM market, known...
Today's Sponsors
Today's Sponsor